Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

CALA - Calithera Biosciences Inc

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, Mar 28, 2017.

Tags:
  1. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare; and license and research agreement with High Point Pharmaceuticals, LLC and TransTech Pharma LLC to develop and commercialize hexokinase II inhibitors. In addition, it has clinical trial collaboration with Bristol-Myers Squibb Company to evaluate Opdivo (nivolumab) in combination with CB-839 in clear cell renal cell carcinoma. The company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of CB-1158, a small molecule arginase inhibitor for the treatment of hematology and oncology. Calithera Biosciences, Inc. was founded in 2010 and is headquartered in South San Francisco, California.

    [​IMG]
     
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Calithera to Receive $12 Million Milestone Payment From Incyte for Achievement of Pharmacokinetic and Pharmacodynamic Goals in Phase 1 Study


    “We are very excited to achieve this early milestone under our collaboration with Incyte as CB-1158 has demonstrated the desired pharmacologic activity in humans, with a corresponding elevation in plasma arginine levels to those achieved with efficacious doses in preclinical models of cancer. Through our collaboration with Incyte, we will continue to evaluate the role of arginase inhibition in the immuno-oncology setting with CB-1158 and we expect to present additional clinical data mid-2017,” said Susan Molineaux, President and Chief Executive Officer of Calithera Biosciences.

    In January, 2017, Calithera and Incyte established a global collaboration and license agreement for the research, development and commercialization of Calithera’s first-in-class, small molecule arginase inhibitor CB-1158 in hematology and oncology. CB-1158 is currently being studied in a monotherapy dose escalation clinical trial and also in combination with anti-PD-1 therapy. Additional studies are expected to evaluate CB-1158 in combination with other immuno-oncology agents.
     
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Nice breakout to new highs today!

    Amazing move, I wish I was holding!
     
  4. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Keeps powering higher, this run has some legs!
     
  5. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
    Nice little move on Monday - looks ready for more.
     
  6. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
    Took all day & still not pushing through resistance - out @ $17.65. Now watch it will do a NERV move and go tomorrow:rolleyes:
     
  7. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
    scared trader = selling too soon >> $20 close :( Wonder how much more it's got?
     
  8. MiguelHammond10

    Joined:
    Jun 12, 2017
    Messages:
    74
    Likes Received:
    5
    Using all CAPS will take this stock to the moon! by Friday!!!
    I'm in, looks good price.
     

Share This Page